Erythropoietin receptor peptide formulations and uses
US8324159B2 · kind B2 · utility
0Cited by
67References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2008 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Jan 12, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.